After ending the month of February on a weak note, what does the first week of March have in store for biotech stocks? Today’s article… Read More »After Last Week’s Weakness, What Does This Week Have In Store For Biotech Stocks?
Regardless of whether the COVID-19 pandemic abates this year or not, the telehealth trend is expected to continue – and that could help one of… Read More »A Return To Normal Or More ‘New Normal’, 2 Healthcare Stocks That Could Soar This Year
With several smaller drug and biotech companies still to report fourth-quarter earnings, today’s article highlights four which are expected to deliver earnings surprises in their… Read More »4 Drug/Biotech Stocks Set To Deliver Earnings Surprises
“The unfolding legalization of marijuana in U.S. states makes this a complicated and potentially lucrative space for investors,” notes the author of today’s article. But… Read More »Why Marijuana Investors May Want To Rethink The Companies They’re Focused On
In the genome sequencing space, the stock highlighted in today’s article may not be the best stock – yet. As the author details, however, “when… Read More »This Genome Sequencing Stock’s Monster Run May Be Far From Over
Among the five new biotech stocks to watch highlighted in today’s article are plays that cross over into pet care, robotics, life sciences and psychedelic… Read More »From Pet Care To Psychedelics, 5 New Biotech Stocks To Watch – And More!
The wave of biotech IPOs continued on Friday, with seven companies in the biotech or health-care space making their market debuts. Among them was a… Read More »7 Newly Listed Biotech/Health-Care Stocks – And A Look At Their Market Debuts
Today’s article highlights two clinical-stage biotech stocks that analysts believe are not only likely to be winners this year, but that have the potential to… Read More »These 2 Biotech Stocks Could Double – Or More – This Year
“While more suited for aggressive investors, and with the number of new traders skyrocketing over the past year and making good ideas to trade even… Read More »Biotech, Women’s Intimate Health & More: 5 Stocks Under $10 Offering Solid Alpha Potential
Both of the biotech stocks highlighted in today’s article have potential game-changer drugs being reviewed for approval by the FDA – one that could delay… Read More »Are These 2 Biotech Stocks With Potential Game-Changer Drugs Being Reviewed For Approval Buys?